238 related articles for article (PubMed ID: 16995857)
1. Solution NMR structure of a human FGF-1 monomer, activated by a hexasaccharide heparin-analogue.
Canales A; Lozano R; López-Méndez B; Angulo J; Ojeda R; Nieto PM; Martín-Lomas M; Giménez-Gallego G; Jiménez-Barbero J
FEBS J; 2006 Oct; 273(20):4716-27. PubMed ID: 16995857
[TBL] [Abstract][Full Text] [Related]
2. Conformational flexibility of a synthetic glycosylaminoglycan bound to a fibroblast growth factor. FGF-1 recognizes both the (1)C(4) and (2)S(O) conformations of a bioactive heparin-like hexasaccharide.
Canales A; Angulo J; Ojeda R; Bruix M; Fayos R; Lozano R; Giménez-Gallego G; Martín-Lomas M; Nieto PM; Jiménez-Barbero J
J Am Chem Soc; 2005 Apr; 127(16):5778-9. PubMed ID: 15839662
[TBL] [Abstract][Full Text] [Related]
3. Properly oriented heparin-decasaccharide-induced dimers are the biologically active form of basic fibroblast growth factor.
Moy FJ; Safran M; Seddon AP; Kitchen D; Böhlen P; Aviezer D; Yayon A; Powers R
Biochemistry; 1997 Apr; 36(16):4782-91. PubMed ID: 9125499
[TBL] [Abstract][Full Text] [Related]
4. Structure of a heparin-linked biologically active dimer of fibroblast growth factor.
DiGabriele AD; Lax I; Chen DI; Svahn CM; Jaye M; Schlessinger J; Hendrickson WA
Nature; 1998 Jun; 393(6687):812-7. PubMed ID: 9655399
[TBL] [Abstract][Full Text] [Related]
5. Heparin-dependent fibroblast growth factor activities: effects of defined heparin oligosaccharides.
Zhou FY; Kan M; Owens RT; McKeehan WL; Thompson JA; Linhardt RJ; Höök M
Eur J Cell Biol; 1997 May; 73(1):71-80. PubMed ID: 9174673
[TBL] [Abstract][Full Text] [Related]
6. Backbone dynamics of a biologically active human FGF-1 monomer, complexed to a hexasaccharide heparin-analogue, by 15N NMR relaxation methods.
Canales-Mayordomo A; Fayos R; Angulo J; Ojeda R; Martín-Pastor M; Nieto PM; Martín-Lomas M; Lozano R; Giménez-Gallego G; Jiménez-Barbero J
J Biomol NMR; 2006 Aug; 35(4):225-39. PubMed ID: 16937240
[TBL] [Abstract][Full Text] [Related]
7. Solution structure of human acidic fibroblast growth factor and interaction with heparin-derived hexasaccharide.
Ogura K; Nagata K; Hatanaka H; Habuchi H; Kimata K; Tate S; Ravera MW; Jaye M; Schlessinger J; Inagaki F
J Biomol NMR; 1999 Jan; 13(1):11-24. PubMed ID: 10070748
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, FGF-1 binding, and molecular modeling studies of conformationally flexible heparin mimetic disaccharides.
Liu L; Bytheway I; Karoli T; Fairweather JK; Cochran S; Li C; Ferro V
Bioorg Med Chem Lett; 2008 Jan; 18(1):344-9. PubMed ID: 17981035
[TBL] [Abstract][Full Text] [Related]
9. 3D structure of a heparin mimetic analogue of a FGF-1 activator. A NMR and molecular modelling study.
Muñoz-García JC; Solera C; Carrero P; de Paz JL; Angulo J; Nieto PM
Org Biomol Chem; 2013 Dec; 11(47):8269-75. PubMed ID: 24178304
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional structure of acidic fibroblast growth factor in solution: effects of binding to a heparin functional analog.
Pineda-Lucena A; Jiménez MA; Lozano RM; Nieto JL; Santoro J; Rico M; Giménez-Gallego G
J Mol Biol; 1996 Nov; 264(1):162-78. PubMed ID: 8950275
[TBL] [Abstract][Full Text] [Related]
11. The activation of fibroblast growth factors (FGFs) by glycosaminoglycans: influence of the sulfation pattern on the biological activity of FGF-1.
Angulo J; Ojeda R; de Paz JL; Lucas R; Nieto PM; Lozano RM; Redondo-Horcajo M; Giménez-Gallego G; Martín-Lomas M
Chembiochem; 2004 Jan; 5(1):55-61. PubMed ID: 14695513
[TBL] [Abstract][Full Text] [Related]
12. Active conformations of glycosaminoglycans. NMR determination of the conformation of heparin sequences complexed with antithrombin and fibroblast growth factors in solution.
Hricovíni M; Guerrini M; Bisio A; Torri G; Naggi A; Casu B
Semin Thromb Hemost; 2002 Aug; 28(4):325-34. PubMed ID: 12244479
[TBL] [Abstract][Full Text] [Related]
13. Microarrays of synthetic heparin oligosaccharides.
de Paz JL; Noti C; Seeberger PH
J Am Chem Soc; 2006 Mar; 128(9):2766-7. PubMed ID: 16506732
[TBL] [Abstract][Full Text] [Related]
14. Sulfated oligosaccharides (heparin and fucoidan) binding and dimerization of stromal cell-derived factor-1 (SDF-1/CXCL 12) are coupled as evidenced by affinity CE-MS analysis.
Fermas S; Gonnet F; Sutton A; Charnaux N; Mulloy B; Du Y; Baleux F; Daniel R
Glycobiology; 2008 Dec; 18(12):1054-64. PubMed ID: 18796646
[TBL] [Abstract][Full Text] [Related]
15. Preparation and use of microarrays containing synthetic heparin oligosaccharides for the rapid analysis of heparin-protein interactions.
Noti C; de Paz JL; Polito L; Seeberger PH
Chemistry; 2006 Nov; 12(34):8664-86. PubMed ID: 17066397
[TBL] [Abstract][Full Text] [Related]
16. S100A13-C2A binary complex structure-a key component in the acidic fibroblast growth factor for the non-classical pathway.
Mohan SK; Rani SG; Kumar SM; Yu C
Biochem Biophys Res Commun; 2009 Mar; 380(3):514-9. PubMed ID: 19284995
[TBL] [Abstract][Full Text] [Related]
17. Physical stabilization of acidic fibroblast growth factor by polyanions.
Volkin DB; Tsai PK; Dabora JM; Gress JO; Burke CJ; Linhardt RJ; Middaugh CR
Arch Biochem Biophys; 1993 Jan; 300(1):30-41. PubMed ID: 7678726
[TBL] [Abstract][Full Text] [Related]
18. Heparin modulates the mitogenic activity of fibroblast growth factor by inducing dimerization of its receptor. a 3D view by using NMR.
Nieto L; Canales Á; Fernández IS; Santillana E; González-Corrochano R; Redondo-Horcajo M; Cañada FJ; Nieto P; Martín-Lomas M; Giménez-Gallego G; Jiménez-Barbero J
Chembiochem; 2013 Sep; 14(14):1732-44. PubMed ID: 23940086
[TBL] [Abstract][Full Text] [Related]
19. Dynamic properties of biologically active synthetic heparin-like hexasaccharides.
Angulo J; Hricovíni M; Gairi M; Guerrini M; de Paz JL; Ojeda R; Martín-Lomas M; Nieto PM
Glycobiology; 2005 Oct; 15(10):1008-15. PubMed ID: 15958415
[TBL] [Abstract][Full Text] [Related]
20. Minimal heparin/heparan sulfate sequences for binding to fibroblast growth factor-1.
Guerrini M; Agulles T; Bisio A; Hricovini M; Lay L; Naggi A; Poletti L; Sturiale L; Torri G; Casu B
Biochem Biophys Res Commun; 2002 Mar; 292(1):222-30. PubMed ID: 11890696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
